Last reviewed · How we verify
NCT04740294
Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis
Phase 2, PHASE3 trial testing Magnesium Sulfate in Bronchiolitis, Viral in 40 participants. Participants enrolled and being followed up; not accepting new ones.
30 June 2025
Quick facts
| Lead sponsor | University of Louisville |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 21 July 2021 |
| Primary completion | 30 June 2025 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Magnesium Sulfate — full drug profile →
Conditions studied
- Bronchiolitis, Viral — all drugs for Bronchiolitis, Viral →
Sponsor
University of Louisville
Who can join
Adults 1 Month to 12 Months, any sex, with Bronchiolitis, Viral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to more rigorously evaluate the response to a single bolus of magnesium sulfate in a population of patients with moderate to severe bronchiolitis. The primary outcome will be to evaluate the effect of this therapy on clinical respiratory status. Secondary outcomes of interest will include the incidence of adverse effects and safety profile of magnesium bolus use in this population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04740294
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnesium Sulfate
Trials testing the same drug.
- NCT07478055 — Biomarkers in Management of Post Partum Preeclampsia · Phase 4 · not yet recruiting
- NCT06811233 — Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study · Phase 2 · recruiting
- NCT06455514 — Post-CA Neuroprotection With Magnesium · Phase 1 · recruiting
- NCT06131905 — Magnesium Sulfate as an Adjuvant to Propofol During Consious Sedation in Colonoscopy · Phase 2, PHASE3 · unknown
- NCT05343806 — Nifedipine Versus Magnesium Sulfate for Late Preterm Tocolysis · NA · unknown
Other University of Louisville trials
Trials by the same sponsor.
- NCT07219888 — Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty · Phase 4 · not yet recruiting
- NCT07044726 — Betadine vs Sterile Water for Periurethral Preparation · Phase 4 · not yet recruiting
- NCT06489106 — Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury · NA · enrolling by invitation
- NCT06883513 — Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID · NA · recruiting
- NCT05920720 — Self-Guided Personalized Treatment for Women · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04740294 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Louisville
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04740294.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing